US 9873876
Cancer treatment
granted A61KA61K31/7115A61K31/712
Quick answer
US patent 9873876 (Cancer treatment) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K31/7115, A61K31/712, A61K31/7125, A61P